MM - 1833
Elranatamab in Combination With Daratumumab and Lenalidomide (EDR) in Transplant-Ineligible (TI) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From MagnetisMM-6 Part
Carmine Liberatore, Sherry Mathew
Poster Presenter: Sherry Mathew